why choose us

First received: June 15, 2023

Clinical Trial: A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Panic Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder

Brief Summary: The purpose of this trial is to measure the efficacy, safety, and tolerability of darigabat (25 milligrams [mg] twice daily [BID]) compared with placebo in participants with panic disorder.

Read more